Thursday 2 June 2022

Protagonist Therapeutics to Present Updated Phase 2 Rusfertide Clinical Results in Polycythemia Vera (PV) at ASCO 2022 - Yahoo Finance

Protagonist Therapeutics to Present Updated Phase 2 Rusfertide Clinical Results in Polycythemia Vera (PV) at ASCO 2022  Yahoo Finance

from "phlebotomist" - Google News https://yhoo.it/3a1vL9K

No comments:

Post a Comment